Evaluation of Clinical Remission in IDDM Patiets Treated With Intravenous Insulin at Onset: Three years follow-up results
Journal Title: Turkish Journal of Endocrinology and Metabolism - Year 1998, Vol 2, Issue 4
Abstract
It has been suggested that strict metabolic control starting from the first weeks of insulin dependent diabetes (IDDM) is a major factor achieving clinical remission. This is usually accompanied with an increase in C-peptide secretion. Long term benefit of remisson might be related with the prevention and/or at least reduction in the rate of development of late diabetic complications. To achieve good metabolic control, intensified insulin therapy and blood glucose monitoring accompanied to a well-planned dietary regimen and physical exercise are crucial elements. Home blood glucose monitoring has been shown to be also an important factor to obtain such a good metabolic control. Aims of this prospective pilot study were a) to evaluate the frequency and duration of clinical remission in newly diagnosed IDDM patients who were followed up for a period of 36 months using a unique protocol without any adjunctive immun-intervention; b) to identify the predictive factors for remission in IDDM patients . 10 newly diagnosed IDDM patients (4 females, 6 males; mean chronological age: 14.8±6.3 yrs) who were classified WHO criteria were included in this study to test the efficacy of intensive insulin therapy (IIT) in achieving clinical remission of the disease. Patients were treated with intravenous insulin infusion at diagnosis for 2-4 days and then IIT was continued with four daily injections. A complete remission (CR) was observed in 50% of cases (5 patients); additionally in three patients insulin requirements reduced to an incomplete remission (ICR) level (30%) No remission (NR) was obtained in the remaining two (20%). Based on remission status, initial characteristics [sex, F/M, mean age onset(years), basal / stimulated C-peptide levels (ng/ml)] were as follows. In CR Group: 1/ 4, 19.1, 1.08± 0.35/ 1.82± 0.4; In ICR Group: 3/ 0, 15.4, 0.61± 0.43 / 1.01±0.56;: In NR Group; 2/ 0, 13.8, 0.28±0.20 / 0.46 ± 0.19, respectively. All groups were evaluated at 3., 6., 12., 24. and 36. months in terms of remission status and beta cell insulin capacity. Mean length of the remission in CR group was 12.4 months . Remission for more than 2 years in one case. In conclusion, this study indicated that remission phenomenon is more frequent than expected without immune-intervention. Older age at onset, male gender and higher initial C- peptide levels seemed to be a predictive of clinical remission in IDDM patients.
Authors and Affiliations
Nevin Dinççağ, İlhan Satman, Emel Özer, Kubilay Karşıdağ, M. Temel Yılmaz
Keywords
Related Articles
- EP ID EP84446
- DOI -
- Views 157
- Downloads 0
Plasma Leptin Levels Before and After Bromocriptine Treatment in Female Patients with Prolactinoma
Both It is known that increased body weight is associated with prolactinomas. However, effects of bromocriptine treatment on plasma leptin levels is not clear yet. The aim of this is to evaluate leptin levels before and...
The Level of Antithrombin III (AT III) in Turkish Diabetics
A natural anti-coagulant AT III plays a defensive role against intravascular coagulation and regulates blood hemostasis. Diabetes is associated with hypercoagulable state. The level of blood AT III levels in the Turkish...
Effects of Dexfenfluramine on Body Weight, Fat Distribution and Lipid Profile in Patients with Obesity
Body weight (BW), body fat ratio (BFR) and serum lipid profile were evaluated in 50 obese patients; 20 treated with a 1100Kcal Standard low calorie diet (group D) and 30 treated with dexfenfluramine (DF) along with the s...
Macroprolactin as a Cause of Hyperprolactinemia: Clinical and Radiological Features
Objective: The aim of this study was to determine the prevalence of macroprolactin in patients with hyperprolactinemia in our region, and to determine the clinical and neuroradiological features of the affected individua...
A Case of Metastatic Follicular Thyroid Carcinoma as a Cause of Thyrotoxicosis
A fifty-eight- year old woman with a history of subtotal thyroidectomy 20 years before was admitted to the hospital because of back ache. Chest computed tomography revealed a mass lesion destroying the ribs and multiple...